
We have discovered the healing effects of antibiotics, the miracles of insulin, and how to map out the human genome. But what will be the next marvellous turning point in the world of medicine?
Flemming Ørnskov, who took over as CEO of Shire Pharmaceuticals about a month ago, has three answers to that question; A breakthrough within gene technology, within mRNA technology, and within stem cell treatments – all areas that Shire work within.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app